Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 18;76(7):1898-1906.
doi: 10.1093/jac/dkab078.

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings

Collaborators, Affiliations

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings

Andrew D Revell et al. J Antimicrob Chemother. .

Abstract

Objectives: With the goal of facilitating the use of HIV-TRePS to optimize therapy in settings with limited healthcare resources, we aimed to develop computational models to predict treatment responses accurately in the absence of commonly used baseline data.

Methods: Twelve sets of random forest models were trained using very large, global datasets to predict either the probability of virological response (classifier models) or the absolute change in viral load in response to a new regimen (absolute models) following virological failure. Two 'standard' models were developed with all baseline variables present and 10 others developed without HIV genotype, time on therapy, CD4 count or any combination of the above.

Results: The standard classifier models achieved an AUC of 0.89 in cross-validation and independent testing. Models with missing variables achieved AUC values of 0.78-0.90. The standard absolute models made predictions that correlated significantly with observed changes in viral load with a mean absolute error of 0.65 log10 copies HIV RNA/mL in cross-validation and 0.69 log10 copies HIV RNA/mL in independent testing. Models with missing variables achieved values of 0.65-0.75 log10 copies HIV RNA/mL. All models identified alternative regimens that were predicted to be effective for the vast majority of cases where the new regimen prescribed in the clinic failed. All models were significantly better predictors of treatment response than genotyping with rules-based interpretation.

Conclusions: These latest models that predict treatment responses accurately, even when a number of baseline variables are not available, are a major advance with greatly enhanced potential benefit, particularly in resource-limited settings. The only obstacle to realizing this potential is the willingness of healthcare professions to use the system.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The standard TCE. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Figure 2.
Figure 2.
Predicted versus observed change in log10-transformed viral load for absolute (A) models with (a) all variables (AG) and (b) without genotype, CD4 count or time on therapy [ANG(−ToT −CD4)]. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.

References

    1. UNAIDS. Seizing the moment. Global AIDS Update 2020. 2020. https://www.unaids.org/en/resources/documents/2020/global-aids-report.
    1. Montaner JS, Lima VD, Harrigan PR. et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in a Canadian setting. PLoS One 2014; 9: e87872. - PMC - PubMed
    1. WHO. HIV Drug Resistance Report 2019. 2019. https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en/.
    1. Saag MS, Benson CA, Gandhi RT. et al. Antiretroviral drugs for the treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel. JAMA 2018; 320: 379–96. - PMC - PubMed
    1. Writing Group, Williams I, Churchill D. et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight). HIV Med 2014; 15 Suppl 1: 1–85. - PubMed

Publication types